Europe & Central Asia vs Iceland: Survival to age 65, male
Europe & Central Asia
78.7%
in 2024
Iceland
91.2%
in 2024
Europe & Central Asia rank
9th
Iceland rank
10th
Survival to age 65, male over time
- Europe & Central Asia
- Iceland
How they compare
Iceland currently reports 91.2% against 78.7% in Europe & Central Asia, a difference of 12.5%.
That makes Iceland's figure about 1.2 times Europe & Central Asia's.
Across all 65 years both countries report, Iceland has been ahead every year.
Europe & Central Asia ranks 9th and Iceland ranks 10th of 47 groups.
Iceland has averaged higher in every one of the 7 decades both report.
Head to head by decade
| Decade | Europe & Central Asia | Iceland | Difference | Ahead |
|---|---|---|---|---|
| 1960s | 64.2% | 74.0% | 9.8% | Iceland |
| 1970s | 64.5% | 75.0% | 10.5% | Iceland |
| 1980s | 66.5% | 79.9% | 13.4% | Iceland |
| 1990s | 66.6% | 83.9% | 17.3% | Iceland |
| 2000s | 69.5% | 87.5% | 18.0% | Iceland |
| 2010s | 75.8% | 89.7% | 13.9% | Iceland |
| 2020s | 77.4% | 87.9% | 10.6% | Iceland |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher survival to age 65, male, Europe & Central Asia or Iceland?
- Iceland, at 91.2% against 78.7% in Europe & Central Asia as of 2024.
- What is the difference in survival to age 65, male between Europe & Central Asia and Iceland?
- 12.5%, with Iceland ahead.
- How many years of comparable data are there for Europe & Central Asia and Iceland?
- 65 years are reported by both, from 1960 to 2024.
- How do Europe & Central Asia and Iceland rank globally for survival to age 65, male?
- Europe & Central Asia ranks 9th and Iceland ranks 10th of 47 groups.
- Where does this data come from?
- World Population Prospects, United Nations (UN), publisher: UN Population Division, published as Survival to age 65, male (% of cohort). Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
Survival to age 65 refers to the percentage of a cohort of newborn infants that would survive to age 65, if subject to age specific mortality rates of the specified year.